Page last updated: 2024-12-06

3,4,3',4'-tetrachloroazoxybenzene

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

3,4,3',4'-Tetrachloroazoxybenzene, also known as TCAB, is a persistent organic pollutant (POP) that has been widely used as a fungicide and insecticide. It is synthesized through the reaction of 3,4-dichloroaniline with sodium nitrite in acidic conditions. TCAB is highly toxic to various organisms and has been found to bioaccumulate in food chains. Its persistence in the environment, its potential for bioaccumulation, and its toxicity have led to concerns about its impacts on human health and ecosystems. Research on TCAB focuses on its environmental fate and transport, its toxicological effects, and its remediation strategies. Studies have investigated its degradation pathways in different environmental compartments, its bioaccumulation in organisms, and its potential for causing endocrine disruption, cancer, and other adverse health effects. Further research is needed to better understand the long-term consequences of TCAB exposure and to develop effective strategies for its control and remediation.'
```

3,4,3',4'-tetrachloroazoxybenzene: unwanted contaminant found in commercial synthesis of dichloroaniline or herbicides made from dichloroaniline; implicated in outbreak of acne in chemical workers [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID30533
MeSH IDM0060910

Synonyms (12)

Synonym
tcaob
bis(3,4-dichlorophenyl)diazene 1-oxide
azoxybenzene, 3,3',4,4'-tetrachloro-
diazene, bis(3,4-dichlorophenyl)-, 1-oxide
3,4,3',4'-tetrachloroazoxybenzene
ccris 3013
1,2-dichloro-4-(3,4-dichlorophenyl)-nno-azoxybenzene
3,3',4,4'-tetrachloroazoxybenzene
21232-47-3
(3,4-dichlorophenyl)-(3,4-dichlorophenyl)imino-oxidoazanium
DTXSID1026087
3,3',4,4'-tetrachloroazoxybenzene 100 microg/ml in acetonitrile

Research Excerpts

Toxicity

ExcerptReferenceRelevance
" Both TCAB and TCAOB were more toxic than all other chemicals that have been tested in the chick embryo with the exception of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD)."( Embryotoxicity of 3,3',4,4'-tetrachloroazobenzene and 3,3',4,4'-tetrachloroazoxybenzene in the chick embryo.
Hsia, MT; Kreamer, BL; Schrankel, KR, 1982
)
0.26

Bioavailability

ExcerptReferenceRelevance
" Absolute bioavailability was calculated to be approximately 9%."( Absorption and disposition kinetics of 3,3',4,4'-tetrachloroazoxybenzene in the male Fischer 344 rat.
Kattnig, MJ; Liebler, DC; Mayersohn, M; Pillai, UA; Sipes, IG; Smith, RL; Ziegler, TL, 1996
)
0.29

Dosage Studied

ExcerptRelevanceReference
" In 2 groups of weanling rats the same dosage of TCAOB was able to reduce the relative thymus weight to 31% and 38% of the comparable control animals."( Thymic atrophy induced by acute exposure of 3,3',4,4'-tetrachloroazobenzene and 3,3',4,4'-tetrachloroazoxybenzene in rats.
Burant, CF; Hsia, MT; Kreamer, BL; Schrankel, KR, 1982
)
0.26
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (22)

TimeframeStudies, This Drug (%)All Drugs %
pre-199017 (77.27)18.7374
1990's4 (18.18)18.2507
2000's1 (4.55)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 11.14

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index11.14 (24.57)
Research Supply Index3.18 (2.92)
Research Growth Index4.31 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (11.14)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other23 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]